Projecten per jaar
Persoonlijk profiel
Expertise
Currently, i'm employed as a PhD-Candidate at the "Laboratory for Molecular and Cellular Therapy" (LMCT) researchgroup at the Vrije Universiteit Brussel. My work entails a jointproject between the LMCT and the "in Vivo Cellular and Molecular Imaging" (ICMI) researchgroups in which I’m investigating the immunogenic properties of targeted radionuclide therapy (TRT) mediated by single domain antibodies (sdAb’s).
Vingerafdruk
Verdiep u in de onderzoeksgebieden waarop Thomas Ertveldt actief is. Deze onderwerplabels komen uit het werk van deze persoon. Samen vormen ze een unieke vingerafdruk.
- 1 Soortgelijke profielen
Netwerk
Recente externe samenwerking op landen-/regioniveau. Duik in de details door op de stippen te klikken of
Projecten
- 1 Afgelopen
-
CS1-specific single-domain antibodies labeled with Actinium-225 prolong survival and increase CD8+ T cells and PD-L1 expression in Multiple Myeloma
De Veirman, K., Puttemans, J., Krasniqi, A., Ertveldt, T., Hanssens, H., Romao, E., Hose, D., Goyvaert, C., Vlummens, P., Muyldermans, S., Breckpot, K., Bruchertseifer, F., Morgenstern, A., D'Huyvetter, M. & Devoogdt, N., 2021, In : Oncoimmunology. 10, 1, 11 blz., 2000699.Onderzoeksoutput: Article
Open Access -
Evaluation of single domain antibodies as nuclear tracers for imaging of the immune checkpoint receptor human lymphocyte activation gene-3 in cancer
Lecocq, Q., Debie, P., Puttemans, J., Awad, R. M., De Beck, L., Ertveldt, T., De Vlaeminck, Y., Goyvaerts, C., Raes, G., Keyaerts, M., Breckpot, K. & Devoogdt, N., 2 nov 2021, In : EJNMMI Research. 11, 1, blz. 1-13 13 blz.Onderzoeksoutput: Article
Open AccessBestand7 Downloads (Pure) -
Formatting and gene-based delivery of a human PD-L1 single domain antibody for immune checkpoint blockade
Awad, R. M., Lecocq, Q., Zeven, K., Ertveldt, T., De Beck, L., Ceuppens, H., Broos, K., De Vlaeminck, Y., Goyvaerts, C., Verdonck, M., Raes, G., Van Parys, A., Cauwels, A., Keyaerts, M., Devoogdt, N. & Breckpot, K., 10 sep 2021, In : Molecular Therapy: Methods & Clinical Development. 22, 9, blz. 172-182 11 blz., 10.Onderzoeksoutput: Article
Open AccessBestand19 Downloads (Pure) -
Gene-based delivery of human PD-L1 single domain antibody formats for immune checkpoint blockade
Awad, R. M., Lecocq, Q., Zeven, K., Ertveldt, T., De Beck, L., Ceuppens, H., Broos, K., De Vlaeminck, Y., Goyvaerts, C., Verdonck, M., Raes, G., Van Parys, A., Cauwels, A., Keyaerts, M., Devoogdt, N. & Breckpot, K., 22 feb 2021.Onderzoeksoutput: Unpublished abstract
Open AccessBestand21 Downloads (Pure) -
Single-Domain Antibody Nuclear Imaging Allows Noninvasive Quantification of LAG-3 Expression by Tumor-Infiltrating Leukocytes and Predicts Response of Immune Checkpoint Blockade
Lecocq, Q., Awad, R. M., De Vlaeminck, Y., de Mey, W., Ertveldt, T., Goyvaerts, C., Raes, G., Thielemans, K., Keyaerts, M., Devoogdt, N. & Breckpot, K., nov 2021, In : Journal of Nuclear Medicine. 62, 11, blz. 1638-1644 7 blz.Onderzoeksoutput: Article
Open AccessBestand4 Downloads (Pure)
-
Nanobody-mediated molecular imaging provides spatiotemporal insight in mRNA-vaccine-induced PD-L1 upregulation
Thomas Ertveldt (Speaker), Sofie Meulewaeter (Speaker), Ine Lentacker (Contributor), Rein Verbeke (Contributor), Stefaan De Smedt (Contributor), Oscar Javier Olarte Rodriguez (Contributor), Kurt Barbé (Contributor), Nick Devoogdt (Contributor), Marleen Keyaerts (Contributor), Heleen Dewitte (Contributor), Karine Breckpot (Contributor)19 apr 2021Activiteit: Talk or presentation at a workshop/seminar
-
Noninvasive imaging and inhibition of human programmed death ligand 1 (PD-L1) using nanobody K2 to improve cancer immunotherapy
Robin Maximilian Awad (Contributor), Dora Mugoli Chigoho (Contributor), Katrijn Broos (Contributor), Quentin Lecocq (Contributor), Katty Zeven (Contributor), Thomas Ertveldt (Contributor), Lien De Beck (Contributor), Hannelore Ceuppens (Contributor), Yannick De Vlaeminck (Contributor), Cleo Goyvaerts (Contributor), Steve Schoonooghe (Contributor), Vicky Caveliers (Contributor), Catarina Xavier (Contributor), Jessica Bridoux (Contributor), Geert Raes (Contributor), Marleen Keyaerts (Contributor), Nick Devoogdt (Contributor), Karine Breckpot (Speaker)25 okt 2021 → 26 okt 2021Activiteit: Talk or presentation at a conference
Bestand
Scriptie
-
Immunogenic effect of targeted radionuclide therapy-induced tumor cell death
Auteur: Ertveldt, T., Breckpot, K., Keyaerts, M., D'Huyvetter, M. & Krasniqi, A., 15 jun 2019Begeleider: Krasniqi, A. (Promotor)
Scriptie/masterproef: Master's Thesis